Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
…, M Uchima, JD Wuerth, K Gatterdam, N Ruetalo… - Science, 2021 - science.org
INTRODUCTION The global scale and rapid spread of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pose unprecedented challenges to society, health care systems, …
coronavirus 2 (SARS-CoV-2) pose unprecedented challenges to society, health care systems, …
[HTML][HTML] Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
M Becker, A Dulovic, D Junker, N Ruetalo… - Nature …, 2021 - nature.com
SARS-CoV-2 is evolving with mutations in the receptor binding domain (RBD) being of
particular concern. It is important to know how much cross-protection is offered between strains …
particular concern. It is important to know how much cross-protection is offered between strains …
[PDF][PDF] Structural and functional framework for the autoinhibition of Nedd4-family ubiquitin ligases
S Mari, N Ruetalo, E Maspero, MC Stoffregen… - Structure, 2014 - cell.com
Nedd4-family ubiquitin ligases are key regulators of cell surface receptor signaling. Their
dysregulation is associated with several human diseases, including cancer. Under normal …
dysregulation is associated with several human diseases, including cancer. Under normal …
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
…, E Ostertag, PD Kaiser, M Gramlich, N Ruetalo… - EMBO …, 2021 - embopress.org
In light of the COVID‐19 pandemic, there is an ongoing need for diagnostic tools to monitor
the immune status of large patient cohorts and the effectiveness of vaccination campaigns. …
the immune status of large patient cohorts and the effectiveness of vaccination campaigns. …
[HTML][HTML] Quinine inhibits infection of human cell lines with SARS-CoV-2
M Große, N Ruetalo, M Layer, D Hu, R Businger… - Viruses, 2021 - mdpi.com
While vaccination campaigns are ongoing worldwide, there is still a tremendous medical
need for efficient antivirals against SARS-CoV-2 infection. Among several drug candidates, …
need for efficient antivirals against SARS-CoV-2 infection. Among several drug candidates, …
[HTML][HTML] Transmission of severe acute respiratory syndrome coronavirus 2 in households with children, southwest Germany, May–August 2020
…, T Ganzenmueller, N Ruetalo… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
Resolving the role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
transmission in households with members from different generations is crucial for containing the …
transmission in households with members from different generations is crucial for containing the …
[HTML][HTML] Iota-carrageenan inhibits replication of SARS-CoV-2 and the respective variants of concern alpha, beta, gamma and delta
…, J Auth, L Spanaus, J Münch, N Ruetalo… - International journal of …, 2021 - mdpi.com
The COVID-19 pandemic continues to spread around the world and remains a major public
health threat. Vaccine inefficiency, vaccination breakthroughs and lack of supply, especially …
health threat. Vaccine inefficiency, vaccination breakthroughs and lack of supply, especially …
[HTML][HTML] Survey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepatica
M Cancela, N Ruétalo, N Dell'Oca, E da Silva… - BMC genomics, 2010 - Springer
Background The common liver fluke Fasciola hepatica is the agent of a zoonosis with significant
economic consequences in livestock production worldwide, and increasing relevance to …
economic consequences in livestock production worldwide, and increasing relevance to …
[HTML][HTML] Structural and enzymatic insights into the ATP binding and autophosphorylation mechanism of a sensor histidine kinase
DesK is a sensor histidine kinase (HK) that allows Bacillus subtilis to respond to cold shock,
triggering the adaptation of membrane fluidity via transcriptional control of a fatty acid …
triggering the adaptation of membrane fluidity via transcriptional control of a fatty acid …
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
TR Wagner, D Schnepf, J Beer, N Ruetalo, K Klingel… - EMBO …, 2022 - embopress.org
The ongoing COVID‐19 pandemic and the emergence of new SARS‐CoV‐2 variants of
concern (VOCs) requires continued development of effective therapeutics. Recently, we …
concern (VOCs) requires continued development of effective therapeutics. Recently, we …